作者: Daniela Santoli , Giovanni Rovera , Alessandra Cesano
DOI:
关键词:
摘要: The invention provides a modified human cytotoxic T cell line, which is characterized by dual activity in vitro and vivo against tumor cells virus-infected cells. Also provided are effective safe methods for use of the adoptive therapy cancer untreatable viral diseases MHC-mismatched recipients, marrow purging to achieve complete eradication residual from marrows patients with leukemia other types cancer. manufacture veterinary composition canine lymphoma feline leukemias.